Expression of IL-21 and IL-33 in Intestinal Mucosa of Inflammatory Bowel Disease: An Immunohistochemical Study

Interleukins are considered to be potential therapeutic targets that can alter the prognosis and disease progression of IBD. IL-21 has proven to be involved in effector Th1, Th2 and Th17 responses. Similarly, IL-33, a newly identified cytokine, has been shown to control the Th1 effector response and...

Descripción completa

Detalles Bibliográficos
Autores principales: Toskas, Alexandros, Milias, Stefanos, Delis, Georgios, Meditskou, Soultana, Sioga, Antonia, Papamitsou, Theodora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340579/
https://www.ncbi.nlm.nih.gov/pubmed/37443579
http://dx.doi.org/10.3390/diagnostics13132185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340579/
https://www.ncbi.nlm.nih.gov/pubmed/37443579
http://dx.doi.org/10.3390/diagnostics13132185

Ejemplares similares